BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18343845)

  • 1. Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.
    Takano T; Katada Y; Moritoh S; Ogasawara M; Satoh K; Satoh R; Tanabe M; Hohdatsu T
    J Gen Virol; 2008 Apr; 89(Pt 4):1025-1029. PubMed ID: 18343845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.
    Takano T; Hohdatsu T; Toda A; Tanabe M; Koyama H
    Virology; 2007 Jul; 364(1):64-72. PubMed ID: 17382365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus.
    Hohdatsu T; Yamada M; Tominaga R; Makino K; Kida K; Koyama H
    J Vet Med Sci; 1998 Jan; 60(1):49-55. PubMed ID: 9492360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection.
    Takano T; Kawakami C; Yamada S; Satoh R; Hohdatsu T
    J Vet Med Sci; 2008 Dec; 70(12):1315-21. PubMed ID: 19122397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.
    Hohdatsu T; Nakamura M; Ishizuka Y; Yamada H; Koyama H
    Arch Virol; 1991; 120(3-4):207-17. PubMed ID: 1659798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes.
    Van Hamme E; Desmarets L; Dewerchin HL; Nauwynck HJ
    Virus Res; 2011 Sep; 160(1-2):32-9. PubMed ID: 21600938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages.
    Hohdatsu T; Tokunaga J; Koyama H
    Arch Virol; 1994; 139(3-4):273-85. PubMed ID: 7832635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of feline infectious peritonitis virus: preparation of monoclonal antibody that shows cell tropism in neutralizing activity after viral absorption into the cells.
    Kida K; Hohdatsu T; Kashimoto-Tokunaga J; Koyama H
    Arch Virol; 2000; 145(1):1-12. PubMed ID: 10664402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.
    Takano T; Yamada S; Doki T; Hohdatsu T
    J Vet Med Sci; 2019 Jun; 81(6):911-915. PubMed ID: 31019150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.
    Tresnan DB; Levis R; Holmes KV
    J Virol; 1996 Dec; 70(12):8669-74. PubMed ID: 8970993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent enhancement of serotype II feline enteric coronavirus infection in primary feline monocytes.
    Takano T; Nakaguchi M; Doki T; Hohdatsu T
    Arch Virol; 2017 Nov; 162(11):3339-3345. PubMed ID: 28730523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.
    Hohdatsu T; Yamato H; Ohkawa T; Kaneko M; Motokawa K; Kusuhara H; Kaneshima T; Arai S; Koyama H
    Vet Microbiol; 2003 Dec; 97(1-2):31-44. PubMed ID: 14637036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus.
    Wasmoen TL; Kadakia NP; Unfer RC; Fickbohm BL; Cook CP; Chu HJ; Acree WM
    Adv Exp Med Biol; 1995; 380():221-8. PubMed ID: 8830483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus.
    Satoh R; Furukawa T; Kotake M; Takano T; Motokawa K; Gemma T; Watanabe R; Arai S; Hohdatsu T
    Vaccine; 2011 Feb; 29(9):1791-800. PubMed ID: 21216312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in virus receptor for type I and type II feline infectious peritonitis virus.
    Hohdatsu T; Izumiya Y; Yokoyama Y; Kida K; Koyama H
    Arch Virol; 1998; 143(5):839-50. PubMed ID: 9645192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of surface expression of feline infectious peritonitis virus (FIPV) antigens on infected cells isolated from cats with FIP.
    Cornelissen E; Dewerchin HL; Van Hamme E; Nauwynck HJ
    Vet Microbiol; 2007 Mar; 121(1-2):131-7. PubMed ID: 17188823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of feline coronaviruses in peripheral blood monocytes.
    Dewerchin HL; Cornelissen E; Nauwynck HJ
    Arch Virol; 2005 Dec; 150(12):2483-500. PubMed ID: 16052283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N.
    Hegyi A; Kolb AF
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1387-91. PubMed ID: 9634079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV).
    Satoh R; Kaku A; Satomura M; Kohori M; Noura K; Furukawa T; Kotake M; Takano T; Hohdatsu T
    J Feline Med Surg; 2011 Jun; 13(6):427-35. PubMed ID: 21334239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus.
    Hu CJ; Chang WS; Fang ZS; Chen YT; Wang WL; Tsai HH; Chueh LL; Takano T; Hohdatsu T; Chen HW
    Sci Rep; 2017 Oct; 7(1):13043. PubMed ID: 29026122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.